Navigation Links
Fate Therapeutics' iPSC Technology Awarded Top Industry Honors for Small Molecule and Protein Reprogramming Breakthroughs
Date:12/21/2009

ethod to recapitulate human physiology for commercial scale drug discovery and therapeutic use. The Company has exclusively in-licensed from The Scripps Research Institute and the Whitehead Institute for Biomedical Research an intellectual property portfolio related to iPSC technology, including filings that date back to November 2003. This portfolio includes the latest techniques published by Dr. Sheng Ding in October 2009, which use three small molecules to generate iPSCs in a manner that is 200 times more efficient than and twice as fast as conventional methods for reprogramming adult human cells.

"Without using dangerous genetic manipulations associated with other methods of reprogramming, Fate Therapeutics has created a powerful platform for safer, more efficient reprogramming of human somatic cells," said Sandhya Kamath, senior research analyst at Frost & Sullivan. "Its protein-only approach to iPSC generation represents a true paradigm shift in reprogramming technology. By maintaining genetic fidelity, biologically-relevant model systems may be created to better understand diseases and to elucidate molecular targets for drug discovery."

In addition to establishing the leading industrialized platform for iPSC technology, Fate Therapeutics is advancing its pipeline of stem cell modulators, which includes FT1050 for the enhancement of hematopoietic stem cell (HSC) proliferation and homing. The small molecule is currently undergoing clinical testing at the Dana Farber Cancer Institute and Massachusetts General Hospital in adult patients with hematologic malignancies, such as leukemia and lymphoma, who have undergone nonmyeloablative conditioning therapy and are in need of HSC support. The Phase 1b study is intended to determine the safety and tolerability of introducing FT1050 during the standard course of dual umbilical cord blood transplant.

About The Scientist's "Top 10 Innovations" List

The Scientist
'/>"/>

SOURCE Fate Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. European Medicines Agency Grants Cell Therapeutics Orphan Drug Designation for Pixantrone in Diffuse Large B-Cell Lymphoma (DLBCL)
2. Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010
3. Cell Therapeutics Announces FDAs Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma, February 10, 2010
4. Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company
5. Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
6. Oxygen Biotherapeutics, Inc. Expands Board of Directors
7. Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign
8. Drug Candidates in Pipeline Offer Potential for Parkinsons Disease Therapeutics Market, Says Frost & Sullivan
9. Hemodynamic Therapeutics Announces Successful Completion of Initial Phase 2 Clinical Study for Novel Combination Hypertension Therapy
10. Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing
11. Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2015)... 25, 2015  With the introduction of Elekta,s new ... radiosurgery are now available for more patients with a ... generation stereotactic radiosurgery system for the brain, integrates advanced ... the versatility of Gamma Knife radiosurgery. Elekta unveiled Leksell ... ESTRO Forum in Barcelona . ...
(Date:4/24/2015)... Today, humanity takes a massive step toward reaching ... cronuts: 1-800 CONTACTS announces their new Apple Watch app which ... Two taps. New contacts. From your watch. ... also features LensGauge which helps keep track of how long ... reorder. "Since our inception, we,ve been dedicated to ...
(Date:4/24/2015)... , April 24, 2015  Perrigo Company plc ... its rejection of the unsolicited offer from Mylan NV ... the outstanding shares of Perrigo for $60.00 per share ... ordinary Perrigo share (the "Offer").  The ... per share significantly undervalued the Company and its future ...
Breaking Medicine Technology:New Leksell Gamma Knife to benefit more patients with brain disease 2New Leksell Gamma Knife to benefit more patients with brain disease 3Attention: We live in the future. Order contact lenses from your wrist with the 1-800 CONTACTS app for Apple Watch 2Perrigo Rejects Mylan Unsolicited Offer 2Perrigo Rejects Mylan Unsolicited Offer 3Perrigo Rejects Mylan Unsolicited Offer 4
... The Barbara Ann Karmanos Cancer Institute announced today that its spin-off ... capital to start the commercialization process of SoftVue, an alternative to mammography. ... (Logo:   http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSLOGO ) , ... SoftVue is a tomographic ultrasound imaging and ...
... 24 Genzyme Corp. has signed a consent decree agreeing to correct manufacturing ... to the federal government $175 million in unlawful profits from the sale ... announced today. , , , ... , , ...
Cached Medicine Technology:Karmanos Cancer Institute's Delphinus Receives $8 Million in Venture Capital for Product Development of Breast Cancer Imaging Tool 2Karmanos Cancer Institute's Delphinus Receives $8 Million in Venture Capital for Product Development of Breast Cancer Imaging Tool 3Karmanos Cancer Institute's Delphinus Receives $8 Million in Venture Capital for Product Development of Breast Cancer Imaging Tool 4Karmanos Cancer Institute's Delphinus Receives $8 Million in Venture Capital for Product Development of Breast Cancer Imaging Tool 5Genzyme Corp. Signs Consent Decree to Correct Violations at Allston, Mass., Manufacturing Plant and Give up $175 Million in Profits 2Genzyme Corp. Signs Consent Decree to Correct Violations at Allston, Mass., Manufacturing Plant and Give up $175 Million in Profits 3
(Date:4/27/2015)... Scooter Direct is now offering Pride Go Go ... only $929.00, marked down from the MSRP of $1605.00. ... for offering quality mobility solutions to its clients. The ... lift chairs, and their accessories at unbeatable prices. ... Go Traveller Elite, a senior store manager stated, “Electric ...
(Date:4/27/2015)... Consumer Choice Award is thrilled to announce the ... Ottawa. We would like to extend heartfelt congratulations to ... has resonated with the people of Ottawa. , Each ... and expectations through the responses of thousands of consumers ... selection process conducted by a third party research firm ...
(Date:4/27/2015)... The Radiology Business Management Association (RBMA) , ... information and intelligence, is proud to announce the launch ... its more than 2,000 members. , “RBMA Washington Insider” ... in that it is exclusively devoted to national health ... newsletter is produced in cooperation with Thorn Run Partners ...
(Date:4/27/2015)... Portland, OR (PRWEB) April 27, 2015 ... such as Lance Armstrong and Alex Rodriguez continue to ... cosmetic neurology present a new frontier in performance enhancement ... of SCI TV , accomplished neuroscientist Anjan ... Pennsylvania talks about the ethics and dangers of these ...
(Date:4/27/2015)... 2015 Jvion, the Atlanta-based leader in ... and recognized as one of the top 40 fastest ... is presented by the Atlanta Business Chronicle, honors Atlanta’s ... status as an economic capital and employment hub. , ... spurred by the growing need to improve healthcare quality ...
Breaking Medicine News(10 mins):Health News:Scooter Direct Offering Pride Go Go Traveller Elite 3-Wheel Scooter At Discounted Price 2Health News:Scooter Direct Offering Pride Go Go Traveller Elite 3-Wheel Scooter At Discounted Price 3Health News:2015 Ottawa Consumer Choice Award-Winners 2Health News:2015 Ottawa Consumer Choice Award-Winners 3Health News:2015 Ottawa Consumer Choice Award-Winners 4Health News:2015 Ottawa Consumer Choice Award-Winners 5Health News:2015 Ottawa Consumer Choice Award-Winners 6Health News:2015 Ottawa Consumer Choice Award-Winners 7Health News:Radiology Business Management Association Launches Weekly Legislative and Policy Newsletter 2Health News:The Brain, Smart Drugs, and Sports on SCI TV with Anjan Chatterjee 2Health News:The Brain, Smart Drugs, and Sports on SCI TV with Anjan Chatterjee 3Health News:Jvion Named to Top 40 Atlanta 2015 Pacesetters 2
... samples, taken from the people of Nandurbar district, is yet ... had spread to humans, even as the culling of thousands ... said the massive culling exercise in the region that reported ... be completed by early Thursday. ,India's first confirmed ...
... a new antifungal drug, for the treatment of bloodstream ... // is indicated in the treatment of candidemia, a ... performance of Eraxis compared to Diflucan, a currently employed ... The drug can also be used in the treatment ...
... Needle– Free Injection System, designed specifically to allow fast, ... itself as a valuable instrument in the fight against ... its patented ability to adjust pressure and volume to ... in a unique situation especially should there be a ...
... although cardiologists are well informed about the possibility of reduction ... eating vegetarian diet, they fail to recommend patients under an ... ,With this on one side, studies conducted on ... they are more than willing to adapt the low-fat diet, ...
... might be able to reduce the harmful effects caused to ... reserachers at the Cornell// University. Foetal Alcohol Syndrome (FAS) results ... known cure for it. ,The reserachers say that ... ill effects of this particular syndrome. The researchers arrived at ...
... considerate bid by EU they have suggested that EU ... bird flu scare due to lowering prices.//, ,Stressing ... "There are different ways for member states to help ... demands that the commission help support businesses in countries ...
Cached Medicine News:Health News:India Awaits Test Results To Confirm The Bird Flu Virus In Humans 2Health News:Needle-Free Injection System Ideal for Pandemic Outbreaks 2Health News:Needle-Free Injection System Ideal for Pandemic Outbreaks 3
... Autocorr Pulse Oximeter with SAC (Serial Autocorrelation) ... software to extract SpO 2 , pulse ... new way. This cost-effective compact monitor ... as standard features, and a data log ...
... Sleep Capnograph/Oximeter was designed with the sleep environment ... measurements of CO 2 and SpO 2 ... used for sleep screening as well as lab-based ... Serial Autocorrelation (SAC) digital pulse oximetry technology for ...
... and Drug Administration (FDA) has granted approval ... for cataract patients with and without presbyopia. ... diffractive technology to give patients a full ... distance) that greatly increases their independence from ...
... The SofPort Advanced Optics Aspheric ... Its the one IOL all your ... best-potential post-operative vision quality and contrast ... the SofPort AO should consistently deliver ...
Medicine Products: